Royalty Pharma RPRX is a prominent buyer of biopharmaceutical royalties and a leading funder of innovation in the industry. Founded in 1996, they have established themselves as the largest buyer of biopharmaceutical royalties. With their extensive experience and expertise, Royalty Pharma plays a crucial role in supporting the development of innovative healthcare solutions.

Royalty Pharma RPRX, , a buyer of biopharmaceutical royalties, is planning to offer 70 million shares priced at $25 to $28 a pop to raise up to $1.96 ...

Royalty Pharma (RPRX) Presents At UBS Global Healthcare Virtual Conference - Slideshow (NASDAQ:RPRX). The following slide deck was published ...

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the ...

Royalty Pharma RPRX

Find contacts at this company